ArticleFrontiers in oncology2024

Conversion therapy for unresectable intrahepatic cholangiocarcinoma using gemcitabine plus S-1 combined with PD-1 inhibitors: a case report.

Shuangying Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.